The Convergence of Health and Tech: Personalizing Medicine Beyond the Imaginable

1:30 PM - 2:45 PM (PDT), Tuesday, June 9, 2020 ・ Click video to start playback;Join Chat Q&A below video
Search General Info
Over the past two decades, genomic sequencing and other new technologies have generated an unprecedented amount of data about the human genome, the cancer genome, and now the immunome, informing our understanding of human health and enabling rapid advances in the development of medicines and diagnostics. Today, we are at the cusp of something even greater – a new frontier of personalized medicine made possible by the convergence of health experts and tech giants working together to accelerate disease detection and treatment like never before.

In this panel, attendees will hear from pioneers in tech and health who are joining forces to transform and personalize disease research, diagnosis and treatment. From decoding the immune system to using AI to super-charge the development of next generation cancer therapies and new regulatory pathways, these novel partnerships are pushing the boundaries of medicine beyond what was previously thought possible.
Moderator
photo
Founder
Astounding HealthTech
Speakers
photo
Principal Deputy Commissioner and Acting Chief Information Officer
Food and Drug Administration
photo
Senior Vice President, Global Research
Amgen Inc.
photo
Global Head of Data Science and AI
Novartis
Peter Lee
Corporate Vice President, AI and Research
Microsoft
photo
Chief Executive Officer & Co-founder
Adaptive Biotechnologies
photo
Founder
Astounding HealthTech